235 related articles for article (PubMed ID: 12859952)
1. Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells.
Kim YI; Park S; Jeoung DI; Lee H
Biochem Biophys Res Commun; 2003 Jul; 307(2):281-9. PubMed ID: 12859952
[TBL] [Abstract][Full Text] [Related]
2. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells.
MacDonald NJ; Freije JM; Stracke ML; Manrow RE; Steeg PS
J Biol Chem; 1996 Oct; 271(41):25107-16. PubMed ID: 8810265
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity.
Lee HY; Lee H
Cancer Lett; 1999 Oct; 145(1-2):93-9. PubMed ID: 10530775
[TBL] [Abstract][Full Text] [Related]
4. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro.
Freije JM; Blay P; MacDonald NJ; Manrow RE; Steeg PS
J Biol Chem; 1997 Feb; 272(9):5525-32. PubMed ID: 9038158
[TBL] [Abstract][Full Text] [Related]
5. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway.
Hartsough MT; Morrison DK; Salerno M; Palmieri D; Ouatas T; Mair M; Patrick J; Steeg PS
J Biol Chem; 2002 Aug; 277(35):32389-99. PubMed ID: 12105213
[TBL] [Abstract][Full Text] [Related]
6. Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability.
Zhou Q; Yang X; Zhu D; Ma L; Zhu W; Sun Z; Yang Q
Biochem Biophys Res Commun; 2007 May; 356(2):348-53. PubMed ID: 17335772
[TBL] [Abstract][Full Text] [Related]
7. A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction.
Chang CL; Strahler JR; Thoraval DH; Qian MG; Hinderer R; Hanash SM
Oncogene; 1996 Feb; 12(3):659-67. PubMed ID: 8637723
[TBL] [Abstract][Full Text] [Related]
8. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity.
Wagner PD; Steeg PS; Vu ND
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9000-5. PubMed ID: 9256424
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis.
Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; Raschellà G
Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphorylation corrects the folding defect of the neuroblastoma (S120G) mutant of human nucleoside diphosphate kinase A/Nm23-H1.
Mocan I; Georgescauld F; Gonin P; Thoraval D; Cervoni L; Giartosio A; Dabernat-Arnaud S; Crouzet M; Lacombe ML; Lascu I
Biochem J; 2007 Apr; 403(1):149-56. PubMed ID: 17155928
[TBL] [Abstract][Full Text] [Related]
11. Structure-based mutational and functional analysis identify human NM23-H2 as a multifunctional enzyme.
Postel EH; Abramczyk BA; Gursky SK; Xu Y
Biochemistry; 2002 May; 41(20):6330-7. PubMed ID: 12009894
[TBL] [Abstract][Full Text] [Related]
12. Identification of structural domains affecting transactivation potential of Nm23.
Cho SJ; Lee NS; Jung YS; Lee H; Lee KJ; Kim E; Chae SK
Biochem Biophys Res Commun; 2001 Dec; 289(3):738-43. PubMed ID: 11726210
[TBL] [Abstract][Full Text] [Related]
13. The human nm23-H4 gene product is a mitochondrial nucleoside diphosphate kinase.
Milon L; Meyer P; Chiadmi M; Munier A; Johansson M; Karlsson A; Lascu I; Capeau J; Janin J; Lacombe ML
J Biol Chem; 2000 May; 275(19):14264-72. PubMed ID: 10799505
[TBL] [Abstract][Full Text] [Related]
14. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
[TBL] [Abstract][Full Text] [Related]
15. Nm23-H1/NDP kinase folding intermediates and cancer: a hypothesis.
Lascu I
J Bioenerg Biomembr; 2006 Aug; 38(3-4):265-8. PubMed ID: 16944300
[TBL] [Abstract][Full Text] [Related]
16. Negative regulation of the antimetastatic gene Nm23-H1 by thyroid hormone receptors.
Lin KH; Shieh HY; Hsu HC
Endocrinology; 2000 Jul; 141(7):2540-7. PubMed ID: 10875256
[TBL] [Abstract][Full Text] [Related]
17. Histidine to aspartate phosphotransferase activity of nm23 proteins: phosphorylation of aldolase C on Asp-319.
Wagner PD; Vu ND
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):623-30. PubMed ID: 10698688
[TBL] [Abstract][Full Text] [Related]
18. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.
Konishi N; Nakaoka S; Tsuzuki T; Matsumoto K; Kitahori Y; Hiasa Y; Urano T; Shiku H
Jpn J Cancer Res; 1993 Oct; 84(10):1050-4. PubMed ID: 7693635
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of colonization and cell-matrix adhesion after nm23-H1 transfection of human prostate carcinoma cells.
Lim S; Lee HY; Lee H
Cancer Lett; 1998 Nov; 133(2):143-9. PubMed ID: 10072163
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of nm23 H1/nucleoside diphosphate kinase A mRNA associated with adenocarcinoma of the prostate.
Jensen SL; Wood DP; Banks ER; Veron M; Lascu I; McRoberts JW; Rangnekar VM
World J Urol; 1996; 14 Suppl 1():S21-5. PubMed ID: 8738406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
